Discover how high-sugar diets contribute to more aggressive lung tumor growth - and how this knowledge could shape future ...

Sutro’s stock tumbled nearly 19% after the company announced it will sideline its FRα-targeted antibody-drug conjugate ...

KRRO-110 is the first RNA editing development candidate from Korro's proprietary OPERA TM platform and is currently being evaluated in the Phase 1/2a REWRITE clinical study for AATD. Dosing of the ...

Many Indians are exposed to silica dust, but experts and patients lament the lack of information and health services related to silicosis. Sophie Cousins reports from West Bengal.

Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on ...

Q4 2024 Earnings Call Transcript March 13, 2025 Blade Air Mobility, Inc. beats earnings expectations. Reported EPS is $-0.08, ...

People with deadly allergies could receive life saving treatment without a needle from a groundbreaking medical device ...

Van Lanschot Kempen Life Sciences Conference MADRID, Spain and CAMBRIDGE, Mass., March 14, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage ...